Notification That Annual Report Will Be Submitted Late (nt 10-k)
May 15 2020 - 06:16AM
Edgar (US Regulatory)
|
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
|
SEC File No: 000-54563
|
|
CUSIP No: 74048 K 10 4
|
|
|
FORM
12b-25
NOTIFICATION
OF LATE FILING
(Check One): [ X ] Form 10-K [ ] Form
20-F [ ] Form 11-K [ ]
Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form
N-CSR
For
Period Ended:
December 31, 2019
☐
|
|
Transition report
on Form 10-K
|
☐
|
|
Transition report
on Form 20-F
|
☐
|
|
Transition report
on Form 11-K
|
☐
|
|
Transition report
on Form 10-Q
|
☐
|
|
Transition report
on Form N-SAR
|
For the
Transition Period Ended:
Nothing
in this form shall be construed to imply that the Commission has
verified any information contained herein.
|
If the
notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification
relates:
__________________________________________________________________________
PART
1 -- REGISTRANT INFORMATION
|
|
Premier
Biomedical, Inc.
|
Full
Name of Registrant
|
|
Former
Name if Applicable
|
|
P.O.
Box 25
|
Address
of Principal Executive Office (Street and Number)
|
|
Jackson
Center, PA 16133
|
City,
State and Zip Code
|
PART
II -- RULES 12b-25(b) AND (c)
If the
subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if
appropriate)
☒
|
|
(a) The
reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or
expense;
|
|
(b) The
subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or a
portion thereof, will be filed on or before the fifteenth calendar
day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, or subject distribution
report on Form 10-D, or portion thereof, will be filed on or before
the fifth calendar day following the prescribed due date;
and
|
|
(c) The
accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
|
PART
III -- NARRATIVE
State
below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K,
10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion
thereof, could not be filed within the prescribed time
period.
The
Form 10-K for the year ended December 31, 2019 could not be filed
within the prescribed time period because we need additional time
to compile and review data and other information regarding certain
material operations of the Company. This data and information are
not currently available and could not be made available without
unreasonable effort and expense. We are actively working to compile
and review this information.
PART
IV-- OTHER INFORMATION
(1)
Name and telephone number of person to contact in regard to this
notification
William
Hartman
|
814
|
786-8849
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of
1934 or Section 30 of the Investment Company Act of 1940 during the
preceding 12 months or for such shorter period that the registrant
was required to file such report(s) been filed? If answer is no,
identify report(s).
[X ]Yes
[ ] No
(3) Is
it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof?
[ ]Yes
[ X ] No
If so,
attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
Premier
Biomedical, Inc.
|
(Name
of Registrant as Specified in Charter)
|
has
caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
Date
|
May 14,
2020
|
By
|
/s/
William A. Hartman
|
|
|
|
William
A. Hartman
|
|
|
|
Chief
Executive Officer
|
Premier Biomedical (PK) (USOTC:BIEI)
Historical Stock Chart
From Apr 2022 to May 2022
Premier Biomedical (PK) (USOTC:BIEI)
Historical Stock Chart
From May 2021 to May 2022